Home
|
Contact
|
Employees
|
Incident Reporting
|
Sitemap
|
Santen Worldwide
Text Size
A
A
A
Search
Menu
About Us
.
About Santen
.
Social Responsibility
.
Products/R&D
.
Careers
.
Customer Information
Santen and Merck & Co., Inc Sign Licensing Agreement for Tafluprost, Treatment for Glaucoma and Ocular Hypertension
Home
› Santen and Merck & Co., Inc Sign Licensing Agreement for Tafluprost, Treatment for Glaucoma and Ocular Hypertension
Santen and Merck & Co., Inc Sign Licensing Agreement for Tafluprost, Treatment for Glaucoma and Ocular Hypertension
Posted
April 15, 2009
by
Read More
Contact
Advanced Vision Science welcomes your inquiries and opinions.
Contact
